FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012097583> ?p ?o ?g. }

• W2012097583 endingPage "1413" @default.
• W2012097583 startingPage "1409" @default.
• W2012097583 abstract "Objective We sought to evaluate the impact of socioeconomic status (SES) on the likelihood of undergoing radical prostatectomy (RP) or external beam radiation therapy (XRT) and the ensuing effect on cancer-specific survival (CSS) after treatment for men with low-risk prostate cancer. Methods Using the California Cancer Registry database, we identified 123,953 men diagnosed with localized, Gleason ≤7 prostate cancer from 1996 to 2005. Patients were separated into quintiles based on socioeconomic status and were stratified by race, age, year of diagnosis, and treatment. Logistic regression and Kaplan-Meier analyses were used to determine the likelihood of undergoing RP or XRT and cancer-specific survival. Results In the final cohort, 39,234 patients (31.7%) and 42,431 patients (34.3%) underwent RP and XRT as initial therapy. Men of lower SES were less likely to undergo RP or XRT. Men undergoing RP in the lowest SES were twice as likely to die of prostate cancer (HR 1.99, 95% CI 1.28-3.09, P = .002) than men in the highest SES. This difference was even more profound when adjusted for race (HR 2.20, 95% CI 1.38-3.50, P = .001). Similarly, men in the lowest SES who underwent XRT were also approximately twice as likely to die of prostate cancer (HR 2.24, 95% CI 1.71-2.94, P <.001) than men of the highest SES, regardless of race. Conclusions Men of lower SES are less likely to undergo RP or XRT for the management of localized prostate cancer. After RP or XRT, men of lower SES have a decreased cancer-specific survival compared with men of higher SES. We sought to evaluate the impact of socioeconomic status (SES) on the likelihood of undergoing radical prostatectomy (RP) or external beam radiation therapy (XRT) and the ensuing effect on cancer-specific survival (CSS) after treatment for men with low-risk prostate cancer. Using the California Cancer Registry database, we identified 123,953 men diagnosed with localized, Gleason ≤7 prostate cancer from 1996 to 2005. Patients were separated into quintiles based on socioeconomic status and were stratified by race, age, year of diagnosis, and treatment. Logistic regression and Kaplan-Meier analyses were used to determine the likelihood of undergoing RP or XRT and cancer-specific survival. In the final cohort, 39,234 patients (31.7%) and 42,431 patients (34.3%) underwent RP and XRT as initial therapy. Men of lower SES were less likely to undergo RP or XRT. Men undergoing RP in the lowest SES were twice as likely to die of prostate cancer (HR 1.99, 95% CI 1.28-3.09, P = .002) than men in the highest SES. This difference was even more profound when adjusted for race (HR 2.20, 95% CI 1.38-3.50, P = .001). Similarly, men in the lowest SES who underwent XRT were also approximately twice as likely to die of prostate cancer (HR 2.24, 95% CI 1.71-2.94, P <.001) than men of the highest SES, regardless of race. Men of lower SES are less likely to undergo RP or XRT for the management of localized prostate cancer. After RP or XRT, men of lower SES have a decreased cancer-specific survival compared with men of higher SES." @default.
• W2012097583 created "2016-06-24" @default.
• W2012097583 creator A5008890760 @default.
• W2012097583 creator A5012233381 @default.
• W2012097583 creator A5016285923 @default.
• W2012097583 creator A5017688201 @default.
• W2012097583 creator A5062478518 @default.
• W2012097583 creator A5086864834 @default.
• W2012097583 date "2010-12-01" @default.
• W2012097583 modified "2023-09-26" @default.
• W2012097583 title "Men of Higher Socioeconomic Status Have Improved Outcomes After Radical Prostatectomy for Localized Prostate Cancer" @default.
• W2012097583 cites W1591554783 @default.
• W2012097583 cites W1969816615 @default.
• W2012097583 cites W1977295323 @default.
• W2012097583 cites W2025383700 @default.
• W2012097583 cites W2026738466 @default.
• W2012097583 cites W2065989613 @default.
• W2012097583 cites W2086691292 @default.
• W2012097583 cites W2099600891 @default.
• W2012097583 cites W2117090889 @default.
• W2012097583 cites W2120449957 @default.
• W2012097583 cites W2138769487 @default.
• W2012097583 cites W2160109879 @default.
• W2012097583 cites W2164062825 @default.
• W2012097583 doi "https://doi.org/10.1016/j.urology.2010.03.024" @default.
• W2012097583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20888034" @default.
• W2012097583 hasPublicationYear "2010" @default.
• W2012097583 type Work @default.
• W2012097583 sameAs 2012097583 @default.
• W2012097583 citedByCount "22" @default.
• W2012097583 countsByYear W20120975832012 @default.
• W2012097583 countsByYear W20120975832015 @default.
• W2012097583 countsByYear W20120975832018 @default.
• W2012097583 countsByYear W20120975832019 @default.
• W2012097583 countsByYear W20120975832020 @default.
• W2012097583 countsByYear W20120975832022 @default.
• W2012097583 crossrefType "journal-article" @default.
• W2012097583 hasAuthorship W2012097583A5008890760 @default.
• W2012097583 hasAuthorship W2012097583A5012233381 @default.
• W2012097583 hasAuthorship W2012097583A5016285923 @default.
• W2012097583 hasAuthorship W2012097583A5017688201 @default.
• W2012097583 hasAuthorship W2012097583A5062478518 @default.
• W2012097583 hasAuthorship W2012097583A5086864834 @default.
• W2012097583 hasConcept C121608353 @default.
• W2012097583 hasConcept C126322002 @default.
• W2012097583 hasConcept C126894567 @default.
• W2012097583 hasConcept C143998085 @default.
• W2012097583 hasConcept C147077947 @default.
• W2012097583 hasConcept C151956035 @default.
• W2012097583 hasConcept C2776235491 @default.
• W2012097583 hasConcept C2778527826 @default.
• W2012097583 hasConcept C2779466945 @default.
• W2012097583 hasConcept C2780192828 @default.
• W2012097583 hasConcept C2908647359 @default.
• W2012097583 hasConcept C29456083 @default.
• W2012097583 hasConcept C509974204 @default.
• W2012097583 hasConcept C71924100 @default.
• W2012097583 hasConcept C72563966 @default.
• W2012097583 hasConcept C99454951 @default.
• W2012097583 hasConceptScore W2012097583C121608353 @default.
• W2012097583 hasConceptScore W2012097583C126322002 @default.
• W2012097583 hasConceptScore W2012097583C126894567 @default.
• W2012097583 hasConceptScore W2012097583C143998085 @default.
• W2012097583 hasConceptScore W2012097583C147077947 @default.
• W2012097583 hasConceptScore W2012097583C151956035 @default.
• W2012097583 hasConceptScore W2012097583C2776235491 @default.
• W2012097583 hasConceptScore W2012097583C2778527826 @default.
• W2012097583 hasConceptScore W2012097583C2779466945 @default.
• W2012097583 hasConceptScore W2012097583C2780192828 @default.
• W2012097583 hasConceptScore W2012097583C2908647359 @default.
• W2012097583 hasConceptScore W2012097583C29456083 @default.
• W2012097583 hasConceptScore W2012097583C509974204 @default.
• W2012097583 hasConceptScore W2012097583C71924100 @default.
• W2012097583 hasConceptScore W2012097583C72563966 @default.
• W2012097583 hasConceptScore W2012097583C99454951 @default.
• W2012097583 hasIssue "6" @default.
• W2012097583 hasLocation W20120975831 @default.
• W2012097583 hasLocation W20120975832 @default.
• W2012097583 hasOpenAccess W2012097583 @default.
• W2012097583 hasPrimaryLocation W20120975831 @default.
• W2012097583 hasRelatedWork W108895284 @default.
• W2012097583 hasRelatedWork W1967410728 @default.
• W2012097583 hasRelatedWork W1982503259 @default.
• W2012097583 hasRelatedWork W2037411085 @default.
• W2012097583 hasRelatedWork W2402249956 @default.
• W2012097583 hasRelatedWork W2545489389 @default.
• W2012097583 hasRelatedWork W2904168711 @default.
• W2012097583 hasRelatedWork W3150909901 @default.
• W2012097583 hasRelatedWork W4246083279 @default.
• W2012097583 hasRelatedWork W193188344 @default.
• W2012097583 hasVolume "76" @default.
• W2012097583 isParatext "false" @default.
• W2012097583 isRetracted "false" @default.
• W2012097583 magId "2012097583" @default.
• W2012097583 workType "article" @default.